Literature DB >> 18361790

An electrophoretic capture method for efficient recovery of rare sequences from heterogeneous DNA.

J Kent Moore1, Jean A Smith, Duncan H Whitney, Kristine H Durkee, Anthony P Shuber.   

Abstract

It is difficult to isolate rare, PCR-quality DNA from specimens containing large quantities of nonspecific DNA from multiple sources (heterogeneous DNA). Extracting human DNA from stool for colorectal cancer (CRC) screening tests exemplifies this technically challenging sample preparation problem. The stool matrix is complex, the DNA composition heterogeneous, and CRC-associated mutated DNA is rare. This report describes a novel solid phase DNA sequence-specific hybrid capture sample preparation method: the reversible electrophoretic capture affinity protocol (RECAP). We show that RECAP, compared with other methods, is capable of extracting linearly increasing amounts of human DNA from increasing amounts of total stool DNA in a manner that avoids co-purifying PCR inhibitors. RECAP thereby increases the yield of rare mutated DNA molecules and thus increases the detection sensitivity for CRC-associated mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18361790     DOI: 10.2144/000112702

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients.

Authors:  Frank Diehl; Kerstin Schmidt; Kristine H Durkee; Kent J Moore; Steve N Goodman; Anthony P Shuber; Kenneth W Kinzler; Bert Vogelstein
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

2.  Sensitive digital quantification of DNA methylation in clinical samples.

Authors:  Meng Li; Wei-Dong Chen; Nickolas Papadopoulos; Steven N Goodman; Niels Christian Bjerregaard; Søren Laurberg; Bernard Levin; Hartmut Juhl; Nadir Arber; Helen Moinova; Kris Durkee; Kerstin Schmidt; Yiping He; Frank Diehl; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler; Sanford D Markowitz; Bert Vogelstein
Journal:  Nat Biotechnol       Date:  2009-08-16       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.